- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Prostatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Prostatic Neoplasms
Total 332 results
-
Louis DOUBLETSeen in:
- Valence, Clinique générale HPDA
Trials:- NCT03580109 (Principal Investigator)
Conditions: -
Louis FrançoisSeen in:
- Pyrénées-Atlantiques, Bayonne, Centre Hospitalier de la Côte Basque
Trials:- NCT03706365 (Principal Investigator)
Conditions: -
Luc Cormier, MD, PhDSeen in:
- Dijon, Department of Urology, CHU Dijon
Trials:- NCT01221168 (Principal Investigator)
Conditions: -
Ludivine CAMBOUSeen in:
- Clermont-Ferrand, CHU Clermont-Ferrand - Urologie
Trials:- NCT05739565 (Sub-Investigator)
Conditions: -
Ludovic OBRINGER, MDSeen in:
- Colmar, Hopitaux civil de Colmar
- Colmar, Hôpital L. Pasteur, Hôpitaux Civils de Colmar
- Colmar, Service d'Urologie, CHU de Guebwiller Colmar
Trials:- NCT05710861 (Principal Investigator)
- NCT03568188 (Principal Investigator)
- NCT03531099 (Principal Investigator)
Conditions: -
Macek PETR, MDSeen in:
- Paris, Institut Mutualiste Montsouris
Trials:- NCT05710861 (Principal Investigator)
Conditions: -
Maël GARROS, MDSeen in:
- Saint-Étienne, Activité Physique Adaptée - DAPAP 42
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Maëva MANUELSeen in:
- Grenoble, Activité Physique Adaptée - CDOS Isère
Trials:- NCT05739565 (Sub-Investigator)
Conditions: -
Magali QUIVRINSeen in:
- Dijon, CLCC Georges-François Leclerc
- Dijon, Centre George Francois Leclerc
- Dijon, Centre Georges François LECLERC
- Dijon, Centre Jean François Leclerc
Trials:- NCT03438552 (Principal Investigator)
- NCT04105920 (Principal Investigator)
- NCT04181203 (Principal Investigator)
- NCT04536805 (Principal Investigator)
- NCT03830788 (Principal Investigator)
-
Manon GIRARD, MDSeen in:
- Grenoble, Activité Physique Adaptée - CDOS Isère
Trials:- NCT05739565 (Principal Investigator)
Conditions: -
Marc COLOMBEL, MDSeen in:
- Lyon, CHRU Hopital Edouard Herriot
- Lyon, Hôpital Hédouard Herriot
- Lyon, Service d'Urologie et Chirurgie de la Transplantation - Hôpital Edouard Herriot - Hospices Civils de Lyon
Trials:- NCT03572621 (Sub-Investigator)
- NCT03088124 (Principal Investigator)
- NCT03960112 (Principal Investigator)
- NCT05714774 (Sub-Investigator)
Conditions: -
Marc-Olivier Bitker, MDSeen in:
- Paris, Department of Urology, Hopital Pitié-Salpetriere
Trials:- NCT01221168 (Principal Investigator)
Conditions: -
Mathieu GrapinSeen in:
- Languedoc-Roussillon, Montpellier, Centre de Cancérologie du Grand Montpellier
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Mathilde CANCELSeen in:
- Tours, University Hospital
Trials:- NCT05415787 (Sub-Investigator)
Conditions: -
Matthieu DURANDSeen in:
- CHU De Nice, Nice, CHU de NICE Pasteur 2
- Nice, CHU de Nice
Trials:- NCT03088124 (Principal Investigator)
- NCT04319146 (Sub-Investigator)
Conditions: -
Matthieu ROUMIGUIE, MDSeen in:
- Toulouse, CHU Toulouse rangueil
Trials:- NCT05710861 (Principal Investigator)
Conditions: -
Maxime THOULOUZAN, MDSeen in:
- Brest, Clinique Keraudren - CHPB
Trials:- NCT04638088 (Principal Investigator)
Conditions: -
Maximilien ROGE, MDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT04536805 (Principal Investigator)
Conditions: -
Mehdi BrahmiSeen in:
- Lyon, Centre Leon Berard
- Lyon, Léon Bérard Center
- Rhone, Lyon cedex 08, Centre Leon Berard
Trials:- NCT04104776 (Principal Investigator)
- NCT04927260 (Principal Investigator)
- NCT04936178 (Principal Investigator)
-
Michel GOZYSeen in:
- Amiens, Clinique de l'Europe
- Amiens, PRIVEE - L'Europe
Trials:- NCT02799706 (Principal Investigator)
- NCT03760822 (Principal Investigator)
-
Michèle FONTAINESeen in:
- Grenoble, Groupe Hospitalier Mutualiste
Trials:- NCT03580109 (Principal Investigator)
Conditions: -
Michèle VIONNET FUASSET, MDSeen in:
- Albertville, Cabinet de médecine vasculaire
Trials:- NCT03580109 (Principal Investigator)
Conditions: -
Morgan Roupret, MD, PhDSeen in:
- Paris, Department of Urology, Hopital Pitié-Salpetriere
Trials:- NCT01221168 (Sub-Investigator)
Conditions: -
Mostefa BennamounSeen in:
- Paris, Institut Mutualiste Montsouris
Trials:- NCT05848011 (Principal Investigator)
Conditions:
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada